Insights for the pharmaceutical supply chain

Explore content based on the incredible wealth of knowledge and experience of our specialists, customers, partners, and other industry experts.

Insights

Read the latest news, views, strategies, and insights on pharma supply chain visibility.

Insight

Disrupting the pharma supply chain with IoT

In their keynote at LogiPharma EU in April 2025, Gísli Herjólfsson (Controlant Co-CEO) and Dino Liquito (Global Logistics Business Partner at Roche) discussed the impact of disruptive technology, such as the Saga Card, and shared insights into the urgency of implementing real-time visibility, with IoT already transforming end-to-end supply chain configuration and transparency.

Insight

Preventing costly delays in clinical trials via real-time shipment tracking

This white paper highlights how real-time monitoring is transforming the clinical supply chain. With 80% of trials delayed by at least a month, real-time tracking reduces costly delays, improves patient safety, and ensures timely delivery of IMPs. This shift minimizes temperature excursions, automates reporting, and enhances transparency, allowing pharmaceutical companies to meet trial deadlines and recruitment goals more effectively. Real-time monitoring is now essential for accelerating drug development and improving trial outcomes.

Insight

How to avoid 16,700t CO2e – a case study with Controlant and Vodafone

A groundbreaking case study conducted by the Carbon Trust, in collaboration with Controlant and Vodafone, highlights the transformative potential of real-time monitoring in pharmaceutical supply chains.

See more articles

Customer stories

Learn how leading pharmaceutical enterprises and logistics companies leverage Controlant's platform and services to transform their supply chains.

Customer story

Digital transformation at work: reshaping the pharma supply chain

Controlant works with global pharmaceutical companies to streamline digital processes to one system across multiple manufacturing sites, helping companies transform the logistical side of their operations with single-source-of-truth visibility.

Customer story

Zero-touch release: creating tangible patient value with the partner ecosystem approach

Dino Liquito, Global PM at Roche, and Gísli Herjólfsson, CEO Controlant, presented at LogiPharma EU 2023 and explained how the two companies have collaborated to extract maximum value from automating the product release process. They illustrated a value case from Intelligent Automation of product release processes – achieving 99.5% release of products with zero human intervention – and a 97% reduction in average release times.

Customer story

Using control tower 2.0 to navigate complexities of temperature-controlled operations

Watch this fireside chat with Tomas Fant, Pfizer’s Head of Temperature Controlled Logistics Projects, and Martin Thaysen, CCO at Controlant, at the LogiPharma EU 2023 event.

News

World Courier and Controlant shortlisted for 2025 Supply Chain Excellence Awards

"The importance of real-time data cannot be overstated. Our devices provide the data that allows World Courier to act before issues arise, ensuring therapies are delivered safely and on time. That's the ultimate goal: making sure patients never have to wait for the treatments they rely on." —Hristo Petkov, SVP Sales, Controlant

News

Results of Controlant’s Annual General Meeting - 5 May 2025

Controlant reports 2024 results, announces new board members and roadmap toward profitability in 2025 Kópavogur, Iceland, 5 May 2025 — Controlant hf., a global leader in real-time supply chain visibility solutions for the pharmaceutical industry, held its Annual General Meeting (AGM) today. All proposals of the Board of Directors to the meeting were approved. The Company’s financial results for 2024 and outlook for 2025 were presented and two new board members were elected.

News

Controlant raises its CDP rating with progress on climate issues

Controlant’s coordinated action on climate issues has been awarded a B rating by the Climate Disclosure Project (CDP). The rating marks an improvement from last year’s B- rating and highlights the company’s steadfast progress toward a low-carbon economy.

More news from Controlant